80 related articles for article (PubMed ID: 6775640)
1. An analogue of thyrotropin releasing hormone with improved biological stability both in vitro and in vivo.
Brewster D; Rance MJ
Biochem Pharmacol; 1980 Oct; 29(19):2619-23. PubMed ID: 6775640
[No Abstract] [Full Text] [Related]
2. Metabolites of thyrotropin releasing hormone inhibit angiotensin converting enzyme in vitro.
MacGregor JS; Resnick LM; Laragh JH
Biochem Biophys Res Commun; 1982 Nov; 109(2):556-61. PubMed ID: 6295402
[No Abstract] [Full Text] [Related]
3. TRH analogue with C-terminal thioamide group: rapid degradation by plasma and its biological effects.
Angyal R; Strbák V; Alexandrová M; Kruszyński M
Endocrinol Exp; 1985 Dec; 19(4):213-9. PubMed ID: 3002750
[TBL] [Abstract][Full Text] [Related]
4. Formation and degradation of deamido-TRH (pyroglutamyl-histidyl-proline) in rat brain after intraventricular injection of TRH.
Spindel ER; Lakher M; Wurtman RJ
Brain Res; 1981 Jul; 216(2):343-50. PubMed ID: 6788347
[TBL] [Abstract][Full Text] [Related]
5. Release of thyrotropin and prolactin by a thyrotropin-releasing hormone (TRH) precursor, TRH-Gly: conversion to TRH is sufficient for in vivo effects.
Pekary AE; Stephens R; Simard M; Pang XP; Smith V; DiStefano JJ; Hershman JM
Neuroendocrinology; 1990 Dec; 52(6):618-25. PubMed ID: 2126612
[TBL] [Abstract][Full Text] [Related]
6. Biological activity of TRH thionalogue and its diastereoisomers.
Alexandrová M; Strbák V; Herman ZS; Stachura Z; Kruszyński M
Endocrinol Exp; 1987 Mar; 21(1):43-9. PubMed ID: 3106009
[TBL] [Abstract][Full Text] [Related]
7. Concentrations of thyrotropin-releasing hormone (TRH) and deamido-TRH, and TRH deamidase activity in brain.
Emerson CH; Vogel W; Currie BL
Endocrinology; 1980 Aug; 107(2):443-9. PubMed ID: 6771121
[No Abstract] [Full Text] [Related]
8. Biologically stable analogues of TRH with increased neuropharmacological potency.
Brewster D; Dettmar PW; Metcalf G
Neuropharmacology; 1981 May; 20(5):497-503. PubMed ID: 6787451
[No Abstract] [Full Text] [Related]
9. Further studies on the effects of a thyrotropin releasing hormone analogue on locomotor activity in the rat.
Clarke KA; Parker AJ
Neuropeptides; 1986; 8(2):99-109. PubMed ID: 3093913
[TBL] [Abstract][Full Text] [Related]
10. Neuropharmacodynamic evaluation of the centrally active thyrotropin-releasing hormone analogue [Leu2]TRH and its chemical brain-targeting system.
Prokai L; Zharikova AD
Brain Res; 2002 Oct; 952(2):268-74. PubMed ID: 12376188
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of thyrotropin-releasing hormone (TRH) and deamido-TRH in the rat.
Safran M; Wu CF; Matys R; Alex S; Emerson CH
Endocrinology; 1984 Sep; 115(3):1031-7. PubMed ID: 6430680
[TBL] [Abstract][Full Text] [Related]
12. Evidence for interplay between thyrotropin-releasing hormone (TRH) and its structural analogue pGlu-Glu-Pro-NH2 ([Glu2]TRH) in the brain: an in vivo microdialysis study.
Nguyen V; Zharikova AD; Prokai L
Neurosci Lett; 2007 Mar; 415(1):64-7. PubMed ID: 17234338
[TBL] [Abstract][Full Text] [Related]
13. Biological evaluation of a TRH analogue with a modified proline residue.
Dettmar PW; Fortune D; Lynn AG; Metcalf G; Morgan BA
Neuropharmacology; 1980 Dec; 19(12):1247-8. PubMed ID: 6777711
[No Abstract] [Full Text] [Related]
14. Prodrug derivatives of thyrotropin-releasing hormone and other peptides.
Bundgaard H; Møss J
Biochem Soc Trans; 1989 Oct; 17(5):947-9. PubMed ID: 2515981
[No Abstract] [Full Text] [Related]
15. Motoneurone excitability after administration of a thyrotrophin releasing hormone analogue.
Clarke KA; Stirk G
Br J Pharmacol; 1983 Nov; 80(3):561-5. PubMed ID: 6416344
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of the phosphinic analogue of thyrotropin releasing hormone.
Matziari M; Bauer K; Dive V; Yiotakis A
J Org Chem; 2008 Nov; 73(21):8591-3. PubMed ID: 18826326
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and biochemical comparison of thyrotropin releasing hormone (TRH) and di-methyl proline-TRH on pituitary GH3 cells.
McDermott AM; Wilkin GP; Dickinson SL
Br J Pharmacol; 1990 Nov; 101(3):615-20. PubMed ID: 1963801
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological observations in patients with motor neuron disease receiving a thyrotropin releasing hormone analogue (RX77368).
Guiloff RJ; Stålberg E; Eckland DJ; Lightman SL
J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1633-40. PubMed ID: 3125307
[TBL] [Abstract][Full Text] [Related]
19. Modification of the proline residue of TRH enhances biological activity and inhibits degradation.
Brewster D; Dettmar PW; Lynn AG; Metcalf G; Morgan BA; Rance MJ
Eur J Pharmacol; 1980 Aug; 66(1):65-71. PubMed ID: 6773784
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal substance P and galanin attenuate TRH analogue-induced wet-dog shake behaviour.
Dixon DM; Fone KC; Bennett GW; Marsden CA
Br J Pharmacol; 1989 Dec; 98 Suppl():829P. PubMed ID: 2482111
[No Abstract] [Full Text] [Related]
[Next] [New Search]
